| Authors: |
Gladwin MT; University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mgladwin@som.umaryland.edu., Gordeuk VR; Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Desai PC; Levine Cancer Institute, Atrium Health, Wake Forest School of Medicine, Charlotte, NC, USA., Minniti C; Albert Einstein College of Medicine, New York, NY, USA., Novelli EM; Department of Medicine, Division of Hematology and Oncology, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, USA., Morris CR; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Department of Pediatric Emergency Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA., Ataga KI; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., De Castro L; Department of Medicine, Division of Hematology and Oncology, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, USA., Curtis SA; Icahn School of Medicine at Mount Sinai, New York, NY, USA., El Rassi F; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA; Georgia Comprehensive Sickle Cell Clinic at Grady Health System, Atlanta, GA, USA., Ford HJ; Pulmonary Hypertension Program, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Harrington T; Division of Hematology, Department of Medicine, University of Miami, Miami, FL, USA., Klings ES; The Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Lanzkron S; Sickle Cell Center for Adults, Johns Hopkins School of Medicine, Baltimore, MD, USA., Liles D; Brody School of Medicine East Carolina University, Greenville, NC, USA., Little J; University of North Carolina Comprehensive Sickle Cell Disease Program and Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Nero A; University of Texas Southwestern Medical Center, Dallas, TX, USA., Smith W; Division of General Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA., Taylor JG 6th; Center for Sickle Cell Disease, Departments of Medicine (Hematology and Oncology) and Microbiology and Immunology, Howard University College of Medicine, Washington, DC, USA; Department of Food and Human Nutrition Sciences, University of Manitoba, Winnipeg, MB, Canada., Baptiste A; Department of Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY, USA., Hagar W; Internal Medicine, Department of Pediatrics, University of California San Francisco, Benioff Children's Hospital Oakland, Oakland, CA, USA., Kanter J; Hematology Oncology, Department of Internal Medicine, University of Alabama Birmingham, Birmingham, AL, USA., Kinzie A; Sickle Cell Center of Southern Louisiana, Tulane University School of Medicine, New Orleans, LA, USA., Martin T; Medical University of South Carolina, Charleston, SC, USA., Rafique A; Sickle Cell Center of Southern Louisiana, Tulane University School of Medicine, New Orleans, LA, USA., Telen MJ; Division of Hematology, Department of Medicine, Duke University School of Medicine, and Duke Comprehensive Sickle Cell Center, Durham, NC, USA., Lalama CM; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Center for Clinical Trials & Data Coordination, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Kato GJ; Department of Medicine, Division of Hematology and Oncology, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, USA., Abebe KZ; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Center for Clinical Trials & Data Coordination, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. |
